Life Science Partner announces the placement of Todd T. Sherer as director of the Office of Technology Transfer and assistant vice president for research at Emory University in Atlanta. Sherer will be responsible for patenting, commercializing and licensing healthcare and technologies developed by Emory University faculty.

Most recently director of technology and research collaborations at Oregon Health & Science University in Portland, Sherer managed an annual operating budget of more than $1.8 million.

Sherer previously directed the Office of Technology Transfer at the University of Oregon in Eugene. He held several different positions focusing on intellectual property and research at Washington State University in Pullman, where he also served as adjunct assistant professor at the College of Pharmacy.

Sherer holds a doctorate from Washington State University and a bachelor of science from Oregon State University.

Learn More About Life Science Partner

Click button below to learn more about how we recruit Chief Executives:

Life Science Partner announces the placement of Sara Toyloy, as vice president, regulatory affairs with Medtronic Vascular in Santa Rosa, California.

Toyloy will work with the senior staff, business units, and geographic areas to set worldwide strategic direction for quality, regulatory affairs, and clinical research.

Toyloy was most recently director, clinical and regulatory affairs for Guidant Vascular. Toyloy began her career in the medical device industry as toxicology and immunology technician with Northview Pacific Laboratories. She later moved into quality assurance, joining Advanced Cardiovascular Systems as preclinical research associate. Toyloy also participated in the development of the artificial heart in Salt Lake City.

Toyloy, who lives in the San Francisco area, earned her bachelor’s in biological sciences from California State University. She is a native of the island of St. Vincent in the Caribbean.

Life Science Partner announces the placement of Scot Webster as vice president, quality with Medtronic in Minneapolis. Webster will collaborate with quality teams within each Medtronic business unit to create and implement company-wide standards for product development, manufacturing, and clinical programs.

Webster was most recently general manager, Global Compliance and Regulatory Affairs for GE Medical. An expert in lean manufacturing, Webster has been pivotal in GE Medical’s Six Sigma initiatives. As one of the company’s Six Sigma leaders, he introduced the program to Asian operations. Webster first joined GE in its television manufacturing division, where, at 25 years old, he became the company’s youngest shop operations manager.

Webster is a 1982 graduate of Bucknell University with a BS in Chemical Engineering.

Life Science Partner announces the placement of Chris Hadland as vice president, quality with Medtronic Vascular in Santa Rosa, California. At this new position, Hadland will establish operational and quality standards, including developing departmental standards programs, defining performance metrics and audit guidelines, measuring the quality program’s impact, and preparing for potential audits.

Hadland was most recently vice president, operations and quality for Timm Medical Technologies. Previously, Hadland was director of quality and regulatory affairs for the Alternate Care Division of Nellcor Puritan Bennett, where he held several positions. Prior to Nellcor, Hadland worked in quality control and assurance for American Medical Systems and Schneider USA.

Hadland, who lives in Minneapolis, earned degrees in chemistry and chemical engineering from St. Olaf College and the University of Minnesota. He also holds an MBA from the College of St. Thomas.

Learn More About Life Science Partner

Click button below to learn more about how we recruit Chief Executives:

Life Science Partner announces the placement of Regina (Reggie) Groves as general manager, patient management with Medtronic Cardiac Rhythm Management in Minneapolis. Groves will lead product development activities, focusing on Internet-based software applications, and infrastructure for connecting patients and physicians to device data and associated services.

Groves was most recently global managing partner, enterprise services for Scient. Prior to its merger with Scient, Groves had joined iXL as senior vice president, healthcare strategy. Groves began her career as director of Florida’s Medicaid Drug Utilization Review, working to reduce inpatient hospitalization by minimizing drug-drug interactions and adverse events through claims analysis and monitoring. Groves then moved to the software company Health Information Designs, where, as national director, she launched a product for monitoring drug-induced disease.

After earning her MBA from Harvard, Groves joined McKinsey’s healthcare practice in Atlanta, where her major clients included Egleston Children’s Hospital — for whom she served as CFO and head of program management — and Kaiser Permanente. Groves graduated from the University of Florida’s School of Pharmacy.